Aurobindo Pharma USA, Inc. recalled a certain lot of depressive disorder medication Mirtazapine in the form of tablets for a label error on declared strength, the U.S. Food and Drug Administration or FDA said in a statement. The East Windsor, New Jersey-based generic pharma company is recalling Mirtazapine tablets of 7.5 mg and 15 mg strengths that are packaged in 500 count bottles.
from RTT - Biotech https://ift.tt/39wU8ay
via IFTTT
No comments:
Post a Comment